Slakter Jason Scott Insider Trades

Insider Trading History

Track insider trading activity for Slakter Jason Scott. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $147k 390,000 shares
Last Trade
Oct 16, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.15M 390,000 shares
$13.20
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $404k 1,067,898 shares
Last Trade
Apr 10, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.3M 242,859 shares
$13.60
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $452k 1,195,724 shares
Last Trade
Jul 18, 2016 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$25.8M 497,859 shares
$51.80
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $350k 925,040 shares
Last Trade
Jun 20, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$485k 8,786 shares
$55.20
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $346k 916,254 shares
Last Trade
May 25, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$233k 3,682 shares
$63.20
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $345k 912,572 shares
Last Trade
May 24, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$467k 7,503 shares
$62.20
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $342k 905,069 shares
Last Trade
May 23, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.28M 20,565 shares
$62.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $334k 884,504 shares
Last Trade
Apr 11, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$406k 6,250 shares
$65.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $332k 878,254 shares
Last Trade
Mar 07, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$454k 6,250 shares
$72.60
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $330k 872,004 shares
Last Trade
Feb 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$379k 6,250 shares
$60.60
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $327k 864,454 shares
Last Trade
Jan 19, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$426k 6,250 shares
$68.20
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $325k 859,504 shares
Last Trade
Jan 07, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36M 350,358 shares
$102.80
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $264k 697,865 shares
Last Trade
Dec 15, 2015 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$46.2M 497,859 shares
$92.80
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $192k 509,146 shares
Last Trade
Dec 07, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$238k 3,000 shares
$79.40
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $191k 506,146 shares
Last Trade
Nov 20, 2015 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$30.8M 428,223 shares
$72.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $29.5k 77,923 shares
Last Trade
Nov 03, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.15k 100 shares
$61.50
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Executive Officer
Holding Value $29.4k 77,823 shares
Last Trade
Nov 02, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$796k 13,250 shares
$60.10
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $18.9k 50,000 shares
Last Trade
Mar 10, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.1M 50,000 shares
$202.80
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $24.4k 64,573 shares
Last Trade
Feb 06, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.15M 29,630 shares
$140.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Director
Holding Value $0 0 shares
Last Trade
Dec 18, 2012 Sale
$633k 16,667 shares
$38.00
$0.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up